In a 69-year-old woman with dysuria, prior persistent vaginal itching despite a single dose of fluconazole 150 mg, urinalysis showing positive leukocyte esterase and pyuria, negative nitrites, no bacteria, and urine culture growing Candida glabrata, should oral fluconazole be started for a presumed symptomatic Candida urinary tract infection?

Do Not Start Fluconazole for This Patient

I would not recommend starting oral fluconazole for this patient's Candida glabrata candiduria. The IDSA guidelines explicitly state that antifungal treatment is NOT recommended for candiduria unless the patient belongs to a high-risk group for dissemination (neutropenic patients, very low-birth-weight infants, or patients undergoing urologic manipulation)—none of which apply here 1.

Why Treatment Is Not Indicated

The Core Problem: Likely Colonization, Not True Infection

This patient's presentation is most consistent with asymptomatic candiduria or vaginal candidiasis causing external dysuria, not a true urinary tract infection:

• Negative nitrites and no bacteria on urinalysis argue strongly against bacterial UTI
• Candida glabrata colony count of 10,000–250,000 CFU/mL is below the typical threshold for symptomatic UTI (usually >10,000 CFU/mL is considered, but clinical context matters)
• Prior persistent vaginal itching despite fluconazole 150 mg once suggests ongoing vulvovaginal candidiasis, which commonly causes external dysuria that mimics UTI
• The pyuria (11–20 WBC/HPF) could reflect vaginal contamination or atrophic changes in a 69-year-old woman 2

C. glabrata Is Frequently Fluconazole-Resistant

Even if treatment were indicated, C. glabrata has inherent reduced susceptibility to fluconazole 1. The guidelines specifically state that for fluconazole-resistant C. glabrata cystitis, amphotericin B deoxycholate (0.3–0.6 mg/kg daily for 1–7 days) OR oral flucytosine (25 mg/kg 4 times daily for 7–10 days) is recommended—not fluconazole 1.

What You Should Do Instead

1. Address the Vaginal Candidiasis First

The persistent vaginal itching despite a single fluconazole dose strongly suggests C. glabrata vulvovaginitis, which is notoriously resistant to oral azoles 1:

• First-line for C. glabrata vulvovaginitis unresponsive to oral azoles: Topical intravaginal boric acid 600 mg daily for 14 days 1
• Alternative: Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
• Third option: Topical 17% flucytosine cream ± 3% amphotericin B cream daily for 14 days 1

2. Remove or Replace the Urinary Catheter (If Present)

The guidelines strongly recommend catheter removal if feasible 1. If this patient has an indwelling catheter (common in hospitalized patients with candiduria), catheter replacement alone clears candiduria in 87–93% of cases within 8 weeks 3.

3. Eliminate Other Predisposing Factors

• Discontinue broad-spectrum antibiotics if possible 4, 5
• Optimize diabetes control if applicable
• Address any urinary obstruction 1

4. Observe Without Treatment

Asymptomatic candiduria resolves spontaneously in 76% of patients without antifungal therapy 6. Even when treated with fluconazole, candiduria recurs at the same rate as placebo at 2-week follow-up 6.

Critical Pitfalls to Avoid

Don't Confuse External Dysuria with True UTI

Vaginal candidiasis causes external dysuria (burning when urine contacts inflamed vulvar tissue) that mimics UTI. The absence of bacteria, negative nitrites, and history of vaginal itching all point to this mechanism rather than bladder infection.

Don't Treat Candiduria Just Because It's There

The presence of Candida in urine does not equal infection requiring treatment in immunocompetent patients 1, 4, 7. Overtreatment drives resistance and exposes patients to unnecessary drug toxicity.

Don't Use Fluconazole for C. glabrata Without Susceptibility Data

C. glabrata has dose-dependent susceptibility to fluconazole at best, and frank resistance is common 1. Azole therapy for C. glabrata vulvovaginitis is frequently unsuccessful 1. If you must treat urinary C. glabrata, amphotericin B or flucytosine are the guideline-recommended agents 1.

When Would Treatment Be Appropriate?

You would treat candiduria in this patient only if:

• She becomes neutropenic (treat as candidemia) 1
• She requires urologic manipulation (prophylaxis with fluconazole 400 mg daily or amphotericin B 0.3–0.6 mg/kg daily for several days before and after the procedure) 1
• She develops symptomatic pyelonephritis with fever, flank pain, and systemic toxicity (treat with fluconazole 200–400 mg daily for 2 weeks if susceptible, or amphotericin B ± flucytosine for resistant organisms) 1

Bottom line: Treat the vaginal candidiasis with topical boric acid or nystatin, remove any catheter, and observe. Do not start fluconazole for the candiduria.